CN102711755A - 用于口服3,3’-二吲哚基甲烷的药物组合物 - Google Patents

用于口服3,3’-二吲哚基甲烷的药物组合物 Download PDF

Info

Publication number
CN102711755A
CN102711755A CN2010800524064A CN201080052406A CN102711755A CN 102711755 A CN102711755 A CN 102711755A CN 2010800524064 A CN2010800524064 A CN 2010800524064A CN 201080052406 A CN201080052406 A CN 201080052406A CN 102711755 A CN102711755 A CN 102711755A
Authority
CN
China
Prior art keywords
dim
pharmaceutical composition
pluronic
diindolylmethane
block copolymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800524064A
Other languages
English (en)
Chinese (zh)
Inventor
V.I.基塞莱夫
I.G.瓦西里瓦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZAKRYTOE AKTSIONERNOE OBSCHESTVO VELES FARMA
Original Assignee
ZAKRYTOE AKTSIONERNOE OBSCHESTVO VELES FARMA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ZAKRYTOE AKTSIONERNOE OBSCHESTVO VELES FARMA filed Critical ZAKRYTOE AKTSIONERNOE OBSCHESTVO VELES FARMA
Publication of CN102711755A publication Critical patent/CN102711755A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN2010800524064A 2009-09-18 2010-09-07 用于口服3,3’-二吲哚基甲烷的药物组合物 Pending CN102711755A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2009134872/15A RU2409363C9 (ru) 2009-09-18 2009-09-18 Фармацевтические композиции для пероральной доставки дииндолилметана (dim) и способы применения этих композиций
RU2009134872 2009-09-18
PCT/RU2010/000487 WO2011034465A1 (ru) 2009-09-18 2010-09-07 Фармацевтическая композиция для пероральной доставки дииндолилметана

Publications (1)

Publication Number Publication Date
CN102711755A true CN102711755A (zh) 2012-10-03

Family

ID=43758874

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800524064A Pending CN102711755A (zh) 2009-09-18 2010-09-07 用于口服3,3’-二吲哚基甲烷的药物组合物

Country Status (10)

Country Link
US (2) US8791150B2 (https=)
EP (1) EP2478904B1 (https=)
JP (1) JP2013505233A (https=)
KR (1) KR20120078722A (https=)
CN (1) CN102711755A (https=)
CA (1) CA2774645C (https=)
EA (1) EA020932B1 (https=)
RU (1) RU2409363C9 (https=)
UA (1) UA102187C2 (https=)
WO (1) WO2011034465A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201105050D0 (en) * 2011-03-25 2011-05-11 Iiaa Ltd Pharmaceutical agent
RU2494733C1 (ru) 2012-10-16 2013-10-10 Всеволод Иванович Киселев Фармацевтическая композиция на основе фитонутриентов с повышенной биодоступностью, обладающая противоопухолевой активностью, и способ ее получения (варианты)
WO2015042170A1 (en) 2013-09-17 2015-03-26 Wayne State University Compositions and uses of combinations of dim-related indoles and selected anti-androgen compounds
ITMI20131924A1 (it) * 2013-11-20 2015-05-21 Cosmo Technologies Ltd Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection emulsioni o microemulsioni per uso nella resezione mucosale endoscopica e/o dissezione submucosale endoscopica
RU2564438C1 (ru) * 2014-07-07 2015-09-27 Закрытое акционерное общество "ИльмиксГрупп" (далее - ЗАО "ИльмиксГрупп") Способ лечения простатической интраэпителиальной неоплазии (пин)
CA2982162C (en) 2015-04-10 2023-10-10 Bioresponse, L.L.C. Self-emulsifying formulations of dim-related indoles
WO2017001979A1 (en) * 2015-06-27 2017-01-05 Reform Bio Inc. Diindolyl methane compositions, formulations and use thereof
GB2565492A (en) * 2016-05-16 2019-02-13 Nordic Labs Ltd Means for treating sexually-transmitted infectious diseases
JP7169591B2 (ja) * 2016-09-15 2022-11-11 スキンテック ライフ サイエンス リミテッド 皮膚疾患の処置のためのｄｉｍの舌下又は頬側の投与
JP6644017B2 (ja) * 2017-03-30 2020-02-12 長弘生物科技股▲ふん▼有限公司 ブチリデンフタリドの用途、その使用方法及びそれを使用して医薬組成物を製造する方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999049851A1 (en) * 1998-04-01 1999-10-07 Bioresponse, L.L.C. Compositions and methods of adjusting steroid hormone metabolism through facilitated absorption of hydrophobic dietary compounds
US6277410B1 (en) * 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
US20040072891A1 (en) * 1999-09-23 2004-04-15 Zeligs Michael A. Phytochemicals for the treatment of mastalgia, endometriosis and HPV-related conditions including cervical dysplasia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6416793B1 (en) * 2000-07-11 2002-07-09 Bioresponse, L.L.C. Formulations and use of controlled-release indole alkaloids
WO2005107747A2 (en) * 2004-05-06 2005-11-17 Bioresponse, Llc Diindolymethane formulations for the treatment of leiomyomas
WO2006060580A1 (en) * 2004-11-30 2006-06-08 Myriad Genetics, Inc. Therapeutic formulations
RU2318509C2 (ru) * 2006-02-10 2008-03-10 Всеволод Иванович Киселев Твердая лекарственная форма дииндолилметана для лечения неопластических заболеваний
EP2265126A4 (en) * 2008-03-10 2011-06-29 Univ Louisville Res Found PROCESS AND COMPOSITIONS FOR THE CONTROLLED DELIVERY OF PHYTOCHEMICALS

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277410B1 (en) * 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
WO1999049851A1 (en) * 1998-04-01 1999-10-07 Bioresponse, L.L.C. Compositions and methods of adjusting steroid hormone metabolism through facilitated absorption of hydrophobic dietary compounds
US20040072891A1 (en) * 1999-09-23 2004-04-15 Zeligs Michael A. Phytochemicals for the treatment of mastalgia, endometriosis and HPV-related conditions including cervical dysplasia

Also Published As

Publication number Publication date
US20130065933A1 (en) 2013-03-14
UA102187C2 (ru) 2013-06-10
EA020932B1 (ru) 2015-02-27
EA201200185A1 (ru) 2012-07-30
RU2409363C1 (ru) 2011-01-20
RU2409363C9 (ru) 2013-12-10
EP2478904A4 (en) 2013-03-06
JP2013505233A (ja) 2013-02-14
US20140303225A1 (en) 2014-10-09
WO2011034465A1 (ru) 2011-03-24
US8791150B2 (en) 2014-07-29
CA2774645C (en) 2018-10-09
CA2774645A1 (en) 2011-03-24
EP2478904A1 (en) 2012-07-25
KR20120078722A (ko) 2012-07-10
EP2478904B1 (en) 2016-03-16

Similar Documents

Publication Publication Date Title
CN102711755A (zh) 用于口服3,3’-二吲哚基甲烷的药物组合物
US12144804B1 (en) Pharmaceutical compositions
KR20170125944A (ko) 고체 분산액
TW201113050A (en) 3-cyanoquinoline tablet formulations and uses thereof
Zhang et al. Targeting delivery of mifepristone to endometrial dysfunctional macrophages for endometriosis therapy
JP2013151574A (ja) チューブリンインヒビターであるインジブリン（Ｉｎｄｉｂｕｌｉｎ）の改良された薬物動態学を有する、経口投与のための薬剤組成物、及びその製造法
US20180015074A1 (en) Use of mtor inhibitors to prevent and regress edhesions and fibrosis
Ye et al. Binary blended co-delivery nanoparticles with the characteristics of precise pH-responsive acting on tumor microenvironment
Wang et al. Evodiamine-loaded rhEGF-conjugated bovine serum albumin nanoparticles alleviate indomethacin-associated gastric mucosal injury in male SD rats
KR20150054543A (ko) 간 표적화 나노입자, 이의 제조방법 및 이를 포함하는 약학적 조성물
EP3746061A1 (en) Use of colchicine to inhibit tumor growth and metastases
CN116850289A (zh) Plk4靶向药物在治疗对铂类药物耐药型肿瘤中的应用
WO2018006689A1 (zh) 氟维司群在制备治疗无功能垂体腺瘤的药物中的用途
CN102258465A (zh) N-(2-(2-胺)氧乙硫基苯并噻唑-6-)-2-甲酰胺衍生物的乳剂及其制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C05 Deemed withdrawal (patent law before 1993)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20121003